ACE inhibitors potential in correcting vessel wall anti-aggregation activity among patients with arterial hypertension and metabolic syndrome

Captopril and fosinopril potential in correcting vascular wall anti-aggregation activity among patients with arterial hypertension (AH) and metabolic syndrome (MS) has been examined. Sixteen-week fosinopril therapy was associated with vascular wall anti-aggregation activity correction. Captopril the...

Full description

Bibliographic Details
Main Authors: I. N. Medvedev, I. N. Mezentseva, V. V. Tolmachev
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2007-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2032